If you are taking medicines on a regular basis, using ADCO - LAMIVUDINE SOLUTION at the same time with another medicine may cause undesirable interactions. Please consult your doctor, pharmacist or other healthcare provider for advice. If you are pregnant or breastfeeding your baby, please consult your doctor, pharmacist or other healthcare provider for advice before taking ADCO-LAMIVUDINE SOLUTION.
ADCO-LAMIVUDINE SOLUTION is not a cure for HIV infection or AIDS. People taking ADCO- LAMIVUDINE SOLUTION may still develop infections or other illnesses associated with HIV disease and AIDS. It is therefore important that you remain under the supervision of your doctor while taking ADCO-LAMIVUDINE SOLUTION. ADCO-LAMIVUDINE SOLUTION does not reduce the risk of passing HIV to others through sexual contact or blood contamination. You should use appropriate precautions.
A condition called lactic acidosis and severe liver disease has occurred with the use of ADCO-LAMIVUDINE SOLUTION. These conditions may result in death.
Do not take ADCO - LAMIVUDINE SOLUTION • If you are hypersensitive (allergic) to lamivudine or any of the other ingredients in ADCO- LAMIVUDINE SOLUTION (listed in section 6).
Warnings and precautions
Take special care with ADCO-LAMIVUDINE SOLUTION:
- If you have, or previously had, a hepatitis B or C infection of the liver. ADCO-LAMIVUDINE SOLUTION may make the infection worse.
- If you develop stomach pain, nausea or vomiting. Check with your doctor, as these could be signs of an inflamed pancreas.
- It may result in a condition called lactic acidosis. If you are feeling unwell, consult your doctor.
- Liver disease has been known to occur.
- If you have kidney disease.
- If you have lipodystrophy (a problem with the way your body uses and stores fat). This condition is characterised by being overweight (obesity), build-up of fat on the back of the neck between the shoulders (buffalo hump), loss of fat under the skin (making the face look thin), breast enlargement and high levels of fat and glucose (sugar) in the blood. If you have any of these signs, you should be thoroughly examined by your doctor.
- If you have advanced HIV infection, your immune system is weak, and you are more likely to develop serious infections (opportunistic infections). Such infections may have been “silent” and not detected by the weakened immune system before treatment was started. After starting treatment, the immune system becomes stronger, and may attack the infections, which can cause symptoms of infection or inflammation. Symptoms usually include fever, plus some of the following: headache, stomach ache or difficulty breathing.
- In rare cases, as your immune system becomes stronger, it can also attack healthy body tissue (autoimmune disorders). The symptoms of autoimmune disorders may develop many months after you start taking medicine to treat your HIV infection.
- If you notice any of these symptoms of osteonecrosis (where parts of the bone tissue die, because of reduced blood supply to the bone): joint aches and pain, joint stiffness or difficulty in movement, tell your doctor.
Other medicines and ADCO-LAMIVUDINE SOLUTION
Always tell your healthcare provider if you are taking any other medicine. (This includes all complementary or traditional medicines.)
There may be an interaction with the following types of medicines:
- Co-trimoxazole, which is an antibiotic used for urinary tract and other infections.
- Zalcitabine an anti-retroviral agent.
- Emtricitabine (used to treat HIV infection).
- Cladribine (used to treat a certain type of cancer).
- Medicines (usually liquids) containing sorbitol and other sugar alcohols (such as xylitol, mannitol, lactitol or maltitol), if taken regularly.
ADCO-LAMIVUDINE SOLUTION with food and drink
ADCO-LAMIVUDINE SOLUTION can be taken with or without food.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, please consult your doctor, pharmacist or other healthcare provider for advice before taking ADCO-LAMIVUDINE SOLUTION.